Overall, limiting the impact of metabolic dysregulation combined with a reduction of inflammation by targeting NF-χβ [77], TNF-α [123], the Jak/Stat pathway [124] and the TGF-β pathway [76] has the potential of reestablishing tissue homeostasis and turning on as a result the immune cancer kill switch. Here, TGFB1 is linked to cancer.